Loading live market data…

Ascendis Pharma A/S

NASDAQ:ASND

$268.57 USD

$3.0 (1.13%)

Volume
434.93K
Average Volume
775.62K
Market Capitalization
$16.68B
P/E Ratio
28.59
Dividend Yield
0.00%
Price Target
$276.50
Year High
$282.15
Year Low
$160.86
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.00

ASND Estimated and Actual Revenue by Quarter

ASND Estimated and Actual EPS by Quarter

ASND Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 5 -478.98M -438.36M -463.03M -487.86M -446.48M -471.61M
2027-09-30 5 -435.39M -398.47M -420.89M -443.46M -405.85M -428.69M
2027-06-30 5 -396.86M -363.21M -383.65M -404.22M -369.94M -390.76M
2027-03-31 5 -342.66M -313.6M -331.25M -349.01M -319.41M -337.39M
2026-12-31 5 -330.78M -302.73M -319.76M -336.9M -308.33M -325.68M
2026-09-30 10 -284.8M -267.29M -276.67M -290.07M -272.24M -281.8M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 5 203.83M 228.8M 219M 3.01B 3.29B 3.18B
2027-09-30 5 172.05M 193.14M 184.86M 2.74B 2.99B 2.89B
2027-06-30 5 142.38M 159.82M 152.97M 2.5B 2.73B 2.64B
2027-03-31 5 114.91M 128.99M 123.46M 2.16B 2.36B 2.28B
2026-12-31 5 70.83M 79.51M 76.1M 2.08B 2.27B 2.2B
2026-09-30 10 34.5M 89.47M 73.1M 1.84B 1.96B 1.9B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 5 554.01M 605.34M 585.19M 2 3.15905 3.54612 3.39412
2027-09-30 5 503.59M 550.25M 531.93M 2 2.66661 2.99333 2.86503
2027-06-30 5 459.03M 501.56M 484.86M 2 2.20669 2.47706 2.37089
2027-03-31 5 396.33M 433.06M 418.64M 2 1.78096 1.99917 1.91348
2026-12-31 5 382.59M 418.04M 404.12M 4 1.09775 1.23226 1.17944
2026-09-30 10 337.81M 359.93M 349.66M 6 0.53473 1.38667 1.1329